Management of Oral Dryness in Sjögren's Syndrome

Treatment Approach

For patients with Sjögren's syndrome who have no salivary output, saliva substitution should be considered the preferred therapeutic approach to alleviate symptoms of oral dryness, as recommended by the European League Against Rheumatism 1, 2
The therapeutic approach to oral dryness in Sjögren's syndrome should be guided by baseline measurement of salivary gland function, not just subjective symptoms, according to the American College of Rheumatology 2
Non-pharmacological stimulation, such as sugar-free acidic candies, lozenges, and xylitol, is recommended as first-line treatment for mild glandular dysfunction, as suggested by the European League Against Rheumatism 1, 2
Pharmacological stimulation with muscarinic agonists, such as pilocarpine and cevimeline, is recommended for moderate glandular dysfunction, as recommended by the American College of Rheumatology 1, 3

Saliva substitutes with neutral pH, containing fluoride and electrolytes, are recommended for severe glandular dysfunction, as suggested by the European League Against Rheumatism 1, 2
Methylcellulose/Hyaluronate-based substitutes are recommended, as they can be applied as needed and are preservative-free, according to the American College of Rheumatology 1, 4
Xylitol-containing oral sprays provide temporary relief and protection against dental caries, as recommended by the American Dental Association 4, 5

Baseline evaluation of salivary gland function is essential before starting treatment for oral dryness, as recommended by the European League Against Rheumatism 6
Saliva substitutes provide symptomatic relief but do not address the underlying disease process, according to the American College of Rheumatology 1
The ideal preparation should have a neutral pH and contain fluoride and electrolytes to mimic natural saliva, as suggested by the European League Against Rheumatism 1, 5

Subjective feelings of dryness may not match objective measurements of glandular function, so baseline evaluation is crucial, as recommended by the American College of Rheumatology 6
Always rule out conditions unrelated to salivary dysfunction, such as candidiasis or burning mouth syndrome, before treatment, according to the European League Against Rheumatism 2, 6
Untreated severe dry mouth can lead to dental caries and eventually tooth loss, emphasizing the importance of prompt and effective management, as recommended by the American Dental Association 5, 7

The American Academy of Ophthalmology recommends starting with 5 mg of pilocarpine four times daily (20 mg/day) for patients with moderate glandular dysfunction, providing significant global improvement in dry mouth symptoms compared to placebo 8, 9

Pilocarpine significantly improves dry eye symptoms, including reduced artificial tear requirement, when the dose is increased to 30 mg/day (7.5 mg four times daily), with a p-value of ≤ 0.0001 8, 9

Excessive sweating occurs in over 40% of patients taking pilocarpine, which is the most common side effect 8, 9
Only 2% of patients discontinued treatment due to side effects at the 20 mg/day dose 8, 9

The guidelines note that while pilocarpine improves dry mouth more consistently than dry eye, most clinical studies demonstrate greater improvement in dry mouth than dry eye 8, 9
For isolated dry eye symptoms, other treatments may be more appropriate, with a study from 2019 suggesting alternative options 10, 8

Cevimeline may have fewer adverse systemic side effects than oral pilocarpine and has been found to improve both ocular irritation symptoms and aqueous tear production 8, 9